跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ARANESP darbepoetin alfa (rch) 300 microgram/0.6mL injection syringe within a pen injector - TGA Drug Approval Details
Approvals
/
TGA
/
ARANESP darbepoetin alfa (rch) 300 microgram/0.6mL injection syringe within a pen injector
Approved
STANDARD
ARANESP darbepoetin alfa (rch) 300 microgram/0.6mL injection syringe within a pen injector
Amgen Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
caa57c524cc909f1
Company
Amgen Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
caa57c524cc909f1
Product Name
ARANESP darbepoetin alfa (rch) 300 microgram/0.6mL injection syringe within a pen injector
Artg Id
122859
Artg Name
ARANESP darbepoetin alfa (rch) 300 microgram/0.6mL injection syringe within a pen injector
Sponsor
Amgen Australia Pty Ltd
Company Detail Path
/organization/amgen-australia-pty-ltd
Artg Date
2006-06-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-04194-3
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
caa57c524cc909f1
Type
Standard
Back to TGA Approvals